Probable regulation of factor VIIa-tissue factor and prothrombinase by factor Xa-TFPI and TFPI in vivo

British Journal of Haematology

Volumn 95, Issue 4, 1996, Pages 738-746

  Gouin Thibault, Isabelle ^a,d   Dewar, Lori ^b   Craven, Sharon ^b   Kulczycky, Myron ^a   Wun, Tze Chein ^c   Ofosu, Frederick A ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b Canadian Red Cross Society   (Canada)

^c MONSANTO COMPANY   (United States)

^d SANOFI   (France)

Author keywords

factor VIIa; factor Xa antithrombin III; factor Xa TFPI; prothrombin fragment 1 + 2; tissue factor

Indexed keywords

BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 7A; PROTHROMBIN FRAGMENT 1; PROTHROMBIN FRAGMENT 2; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; NORMAL HUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM;

EID: 0030445026     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.d01-1963.x     Document Type: Article

References (38)

1. Bauer, K.A., Goodman, T.L, Kass, B.L. & Rosenberg, R.D. (1985) Elevated factor Xa activity in the blood of asymptomatic patients with congenital antithrombin III deficiency. Journal of Clinical Investigation, 76, 826-836.
2. Bauer, K.A., Weiss, L.M. & Sparrow, D. (1987) Aging associated changes in indices of thrombin generation and protein C activation in humans: normative aging study. Journal of Clinical Investigation, 80, 1527-1534.
3. Berrettini, M., Parise, P., Ricotta, S., Iorio, A., Peirone, C. & Nenci, G.G. (1996) Increased plasma levels of tissue factor pathway inhibitor (TFPI) after n-3 polyunsaturated fatty acid supplementation in patients with chronic atherosclerotic disease. Thrombosis and Haemostasis, 73, 395-400.
4. Bognacki, J. & Hammelburger, J. (1995) Functional and immunologic methods for the measurement of human tissue factor pathway inhibitor. Blood Coagulation and Fibrinolysis, 6, S65-S72.
5. Broze, G.J., Jr (1995) Tissue factor pathway inhibitor and the current concept of blood coagulation. Blood Coagulation and Fibrinolysis, 6, (Suppl. 1), S7-S13.
6. Broze, G.J., Jr, Girard, T.J. & Novotny N.F. (1990) Regulation of coagulation by a multivalent Kunitz-type inhibitor. Biochemistry, 29, 7539-7546.
7. Broze, G.J., Jr, Lange, G.W., Duffin, K.L. & MacPhail, L. (1994) Heterogeneity of plasma tissue factor pathway inhibitor. Blood Coagulation and Fibrinolysis, 5, 551-559.
8. Broze G.J., Jr, Warren, L.A., Novotny, W.F., Higuchi, D.A., Girard, T.J. & Miletich, J.P. (1988) The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action. Blood, 71, 335-343.
9. Davie, E.W., Fujikawa, K. & Kisiel, W. (1991) The coagulation cascade: initiation maintenance, and regulation. Biochemistry, 30, 10363-10370.
10. Falanga, A., Ofosu, F.A., Delain, F., Oldani, E., Dewar, L., Liu, L. & Barbui, T. (1994) The hypercoagulable state in cancer patients: evidence for impaired thrombin inhibition. Blood Coagulation and Fibrinolysis, 5, (Suppl. 1), S19-S23.
11. Girard, T.J., MacPhail, L.A., Likert, K.M., Novotny, W.F., Miletich, J.P. & Broze, G.J. (1990) Inhibition of factor VIIa-tissue factor coagulant activity by a hybrid protein. Science, 248, 1421-1424.
12. Gouin-Thibault, I., Dewar, L., Kulczycky, M., Sternbach, M. & Ofosu, F.A. (1995) Measurement of factor Xa-antithrombin III in plasma: relationship to prothrombin activation in vivo. British Journal of Haematology, 90, 669-680.
13. Huang, Z.F., Wun, T.-C. & Broze, G.J., Jr (1993) Kinetics of factor Xa inhibition by tissue factor pathway inhibitor. Journal of Biological Chemistry, 268, 26950-26955.
14. Jesty, J. & Nemerson, Y. (1976) The activation of bovine coagulation factor X. Methods in Enzymology, 45, 1-95.
15. Jesty, J., Wun, T.C. & Lorenz, A. (1994) Kinetics of the inhibition of factor Xa and the tissue factor-factor VIIa complex by the tissue factor pathway inhibitor in the presence and absence of heparin. Biochemistry, 33, 12686-12694.
16. Kalifatis, M. & Mann, K.G. (1993) Role of membrane in the inactivation of factor Va by activated protein C. Journal of Biological Chemistry, 288, 27246-27257.
17. Kazama, Y., Komiyama, Y. & Kisiel, W. (1993) Tissue factor pathway inhibitor and protease nexin-1 are major factor Xa binding proteins on the HepG2 cell surface. Blood, 81, 676-682.
18. Lawson, J.H., Butenas, S., Ribarik, N. & Mann, K.G. (1993) Complex-dependent inhibition of factor VIIa by antithrombin III and heparin. Journal of Biological Chemistry, 268, 767-770.
19. Lindahl, A.K., Sandset, P.M., Abildgaard, U., Andersson, T.R. & Harbitz, T.B. (1989) High plasma levels of extrinsic pathway inhibitor and low levels of other coagulation inhibitors in advanced cancer. Acta Chirurgica Scandinavica, 155, 389-393.
20. Lindhout, T., Franssen, J. & Willems, G. (1995) Kinetics of the inhibition of tissue-factor-factor VIIa by tissue factor pathway inhibitor. Thrombosis and Haemostasis, 74, 910-915.
21. Lindhout, T., Willems, G., Blezer, R. & Hemker, H.C. (1994) Kinetics of the inhibition of human factor Xa by full-length and truncated recombinant tissue factor pathway inhibitor. Biochemical Journal, 297, 131-136.
22. Liu, L., Dewar, L., Song, Y., Kulczycky, M., Blajchman, M.A., Fenton, J.W., II, Andrew, M., Delorme, M., Ginsberg, J., Preissner, K.T. & Ofosu, F.A. (1995) Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo. Thrombosis and Haemostasis, 73, 405-412.
23. Lupu, C., Lupu, F., Dennehy, U., Kakkar, V.V. & Scully, M.F. (1995) Thrombin induces the redistribution and acute release of tissue factor pathway inhibitor from specific granules within human endothelial cells in culture. Atherosclerosis, Thrombosis and Vascular Biology, 15, 2055-2062.
24. Mann, K.G., Jenny, R.J. & Krishnaswamy, S. (1988) Cofactor proteins in the assembly and expression of blood clotting enzyme complexes. Annual Review of Biochemistry, 57, 915-956.
25. Merlini, P.A., Ardissino, D., Oltrona, L., Broccolino, M., Coppola, R. & Mannucci, P.M. (1995) Heightened thrombin formation but normal plasma levels of activated factor VII in patients with acute coronary syndromes. Arteriosclerosis, Thrombosis and Vascular Biology, 15, 1675-1679.
26. McGee, M.P., Foster, S. & Wang, X. (1994) Simultaneous expression of tissue factor and tissue factor pathway inhibitor by human monocytes: a potential mechanism for localized control of blood coagulation. Journal of Experimental Medicine, 179, 1847-1854.
27. Morrissey, J.H., Macig, B.G., Neuenschwander, P.F. & Comp, P.C. (1993) Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood, 81, 734-744.
28. Novotny, W.F. (1994) Tissue factor pathway inhibitor. Seminars on Thrombosis and Hemostasis, 20, 101-8.
29. Ofosu, F.A., Craven, S., Dewar, L., Anvari, N., Andrew, M. & Blajchman, M.A. (1996) Age-related changes in factor VII proteolysis in vivo. British Journal of Haematology, 94, 407-412.
30. Ofosu, F.A., Lormeau, J.C., Craven, S., Dewar, L. & Anvari, N. (1994) Heparin and low molecular weight heparins inhibit prothrombinase formation but not its activity in plasma. Thrombosis and Haemostasis 72, 862-868.
31. Pelzer, H., Schwartz, A. & Stuber, W. (1991) Determination of human prothrombin fragment 1 + 2 in plasma with an antibody against a synthetic peptide. Thrombosis and Haemostasis, 65, 153-159.
32. Rao, L.V., Nordfang, O., Hoang, A.D. & Pendurthi, U.R. (1995) Mechanism of antithrombin III inhibition of factor VIIa/tissue factor activity on cell surfaces: comparison with tissue factor pathway inhibitor/factor Xa-induced inhibition of factor VIIa/ tissue factor activity. Blood, 85, 121-129.
33. Rapaport, S.I. (1989) Inhibition of factor VIIa/tissue factor-induced blood coagulation: with particular emphasis upon a factor Xa-dependent inhibitory mechanism. Blood, 73, 359-365.
34. Rapaport, S.I. (1991) The extrinsic pathway inhibitor: a regulator of tissue-factor-dependent blood coagulation. Thrombosis and Haemostasis, 66, 6-15.
35. Sandset, P.M., Abildgaard, U. & Larsen, M.L. (1988) Heparin induces release of extrinsic coagulation pathway inhibitor (EPI). Thrombosis Research, 50, 803-813.
36. Sandset, P.M., Warn-Cramer, B.J., Rao, L.V.M., Maki, S.L. & Rapaport, S.I. (1991a) Immunodepletion of extrinsic pathway inhibitor sensitizes rabbits to endotoxin induced intravascular coagulation and the generalised Schwartzman reaction. Blood, 78, 1496-1502.
37. Sandset, P.M., Warn-Cramer, B.J., Rao, L.V.M., Maki, S.L. & Rapaport, S.I. (1991b) Depletion of extrinsic pathway inhibitor (EPI) sensitize rabbits to disseminated intravascular coagulation induced with tissue factor: evidence supporting a physiologic role for EPI as a natural anticoagulant. Proceedings of the National Academy of Sciences of the United States of America, 88, 708-812.
38. Warn-Cramer, B.J., Rao, L.V., Maki, S.L. & Rapaport, S.I. (1988) Modifications of extrinsic pathway inhibitor (EPI) and factor Xa that affect their ability to interact and to inhibit factor VIIa/tissue factor: evidence for a two-step model of inhibition. Thrombosis and Haemostasis, 60, 453-456.